Article
Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation.
Clinical endocrinology - 1 Feb 2013
Visser W Edward, Vrijmoeth Paul, Visser Frank E, Arts Willem Frans M, van Toor Hans, Visser Theo J
Abstract excerpt
OBJECTIVE: Monocarboxylate transporter 8 (MCT8) is an essential thyroid hormone (TH) transporter as humans with MCT8 mutations have severe neurological and endocrine abnormalities. The objectives are (i) to identify novel MCT8 mutations and (ii) to assess their functional relevance; (iii) to describe the effects of block-and-replace treatment in an MCT8 patient. DESIGN: The TOP-R study is a cross-sectional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
